Ctbp1 Knockout 3T3-L1 Cell Line

The Ctbp1 Knockout 3T3-L1 Cell Line is a genetically engineered murine preadipocyte model in which the Ctbp1 gene has been disrupted using CRISPR/Cas9-mediated gene editing. This cell line provides a stable loss-of-function tool derived from the well-characterized 3T3-L1 fibroblast line, enabling researchers to dissect Ctbp1 function in transcriptional regulation, adipogenesis, and disease models without the confounding effects of wild-type Ctbp1 activity. By eliminating Ctbp1 expression, this model permits precise interrogation of corepressor-dependent gene silencing mechanisms and downstream phenotypic consequences in a differentiation-competent cellular context.

3T3-L1 cells are a subclone of Swiss 3T3 mouse embryonic fibroblasts that retain the ability to undergo differentiation into mature adipocytes upon exposure to a defined hormonal cocktail (insulin, dexamethasone, and IBMX). This cell line is widely adopted in metabolic research as a model for adipogenic differentiation, lipid metabolism, and insulin signaling. The preadipocyte state and capacity for controlled differentiation make it particularly suitable for studying the molecular events governing the transition from fibroblast to adipocyte, including the roles of transcription factors and chromatin modifiers.

Ctbp1 encodes a transcriptional corepressor that docks to DNA-bound transcription factors such as ZEB1 and E1A-associated proteins, subsequently recruiting chromatin-modifying complexes including HDAC1/2 and CoREST. Through this activity, Ctbp1 represses transcription of tumor suppressors like p21 and Bax, thereby promoting cell survival and proliferation. Ctbp1 functions downstream of multiple signaling cascades, including Wnt/??-catenin, Notch/RBP-J??, TGF-??/Smad, and p53 pathways. For instance, Wnt ligands can regulate Ctbp1 levels, while Notch intracellular domain and TGF-?? signals modulate its repressive functions. Additionally, Ctbp1 interacts with CtIP and forms complexes that influence gene expression programs critical for cell fate decisions.

In the 3T3-L1 preadipocyte context, Ctbp1 knockout serves as a powerful model to investigate transcriptional control of adipogenic differentiation. Ctbp1 has been implicated in the regulation of PPAR??, a master transcription factor driving adipogenesis; disruption of Ctbp1 may alter PPAR?? expression and thus impact lipid accumulation and adipocyte maturation. Given its dual roles in metabolism and oncogenesis, this knockout cell line is uniquely positioned to explore crosstalk between metabolic reprogramming and tumor suppression. For example, researchers can compare the differentiation capacity of knockout versus wild-type cells using Oil Red O staining and assess changes in glucose uptake or lipolysis.

This reagent enables a wide array of experimental applications, including quantifying gene expression changes via RT-qPCR and western blotting; performing chromatin immunoprecipitation (ChIP-qPCR) to map Ctbp1-dependent histone modifications; co-immunoprecipitation to probe protein?Cprotein interactions with HDAC1/2 or ZEB1; and luciferase reporter assays to measure transcriptional activity of Ctbp1-regulated promoters. The cell line is suitable for adipocyte differentiation assays with Oil Red O staining and metabolic phenotyping (glucose uptake, lipolysis). In cancer biology, it can be used to test the hypothesis that Ctbp1 loss sensitizes cells to apoptotic stimuli via derepression of Bax and p21. For drug discovery, the knockout line provides a clean background to validate Ctbp1-targeted small molecules or to screen for compounds that rescue the knockout phenotype. Researchers focused on developmental disorders may investigate how Ctbp1 loss affects Notch or TGF-??-mediated differentiation processes. For further information or to discuss customized applications, please contact Ascent Research.